Literature DB >> 3964795

A prospective study of bone mass in patients with type I diabetes.

S L Hui, S Epstein, C C Johnston.   

Abstract

Sixty-nine patients with type I diabetes mellitus were followed for from 1-4 yr (mean, 3 yr). Their overall growth, as measured by height and weight, was normal; however, repeated measurements of their bone mass using photon absorptiometry and radiogrammetry showed that, relative to normal subjects, the patients had a persistent bone deficit throughout the course of the study. This deficit was not attributable to bone width, which was normal. On the average, the magnitude of the deficit did not change with time; furthermore, an individual's rate of change in bone mass deficit during the study was not correlated with the patient's glucose control, as measured by hemoglobin A-1 or fasting blood glucose levels. Initial levels of serum ionized calcium and magnesium were decreased in the patients with diabetes. During the study, the mean level of ionized calcium increased, but that of magnesium decreased further, compared to the initial values. In a group of 19 patients with newly diagnosed diabetes, bone mass was found to be significantly below normal among the girls, but not among the boys.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964795     DOI: 10.1210/jcem-60-1-74

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

3.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells.

Authors:  A D McCarthy; S B Etcheverry; L Bruzzone; A M Cortizo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

5.  Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.

Authors:  Srividhya Iyer; Li Han; Elena Ambrogini; Maria Yavropoulou; John Fowlkes; Stavros C Manolagas; Maria Almeida
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

6.  Possible mechanism of inhibition of cartilage alkaline phosphatase by insulin.

Authors:  C Gazzarrini; N Stagni; P Pollesello; P D'Andrea; B De Bernard
Journal:  Acta Diabetol Lat       Date:  1989 Oct-Dec

Review 7.  Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Authors:  Christine Hamann; Stephan Kirschner; Klaus-Peter Günther; Lorenz C Hofbauer
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

8.  Heritability of bone mass: a longitudinal study in aging male twins.

Authors:  J C Christian; P L Yu; C W Slemenda; C C Johnston
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

9.  Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa.

Authors:  Monica H Wojcik; Erinne Meenaghan; Elizabeth A Lawson; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  Bone       Date:  2009-11-18       Impact factor: 4.398

10.  Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus.

Authors:  F Corica; R Ientile; A Allegra; G Romano; F Cangemi; A Di Benedetto; M Buemi; D Cucinotta; D Ceruso
Journal:  Biol Trace Elem Res       Date:  1996-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.